https://www.selleckchem.com/products/blu-554.html
herefore, all women with abnormal fetal ultrasound must undergo CMA test for genotype-phenotype correlation. CMA detects known and rare deletion/duplication syndromes and characterizes marker chromosomes. Accumulation of CNV data will form an Indian Repository and also help to resolve the uncertainty of VOUS. Pretest and posttest genetic counseling is essential to convey benefits and limitations of CMA and help the patients to take informed decisions. To compare between postplacental insertion of levonorgestrel intrauterine system versu
पसंद करना
टिप्पणी
शेयर करना
